Cormorant Global Healthcare Master Fund, LP bought $3.0M of Bright Minds Biosciences (DRUG)

Executed Oct 15 2024, disclosed Oct 17 2024, 2 days later.

Value, as filed

$3.0M

400,675 sh across 6 lots

Executed

Oct 15 2024

the trade date, as filed

Disclosed

Oct 17 2024

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

not yet measured

Not yet measured: the 21-session window has not closed, or the prices around it are not on record.

The filer

CL Cormorant Global Healthcare Master Fund, LP Other profile →

Cormorant Global Healthcare Master Fund, LP (Other) filed 1 Form 4 report as a reporting entity in the trailing twelve months (0 purchases, 1 sale), most often in Corbus Pharmaceuticals Holdings, Inc. (CRBP). The largest single filing was $46.8M of MLTX (6,494,151 sh across 4 lots, as filed), executed Sep 29 2025.

The name

DRUG DRUG DRUG · 3 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→